Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis

OBJECTIVE: To evaluate the cost effectiveness of four disease modifying treatments (interferon betas and glatiramer acetate) for relapsing remitting and secondary progressive multiple sclerosis in the United Kingdom. DESIGN: Modelling cost effectiveness. SETTING: UK NHS. PARTICIPANTS: Patients with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Chilcott, Jim, McCabe, Chris, Tappenden, Paul, O'Hagan, Anthony, Cooper, Nicola J, Abrams, Keith, Claxton, Karl
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Group 2003
Konular:
Papers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC150460/
https://ncbi.nlm.nih.gov/pubmed/12623909
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller